Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.000
+0.160 (8.70%)
At close: Dec 20, 2024, 4:00 PM
1.950
-0.050 (-2.50%)
After-hours: Dec 20, 2024, 5:51 PM EST
Immuneering Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 62 | 215 | 128 | 426 | - | - |
| Market Cap Growth | -67.15% | 67.99% | -69.91% | - | - | - |
| Enterprise Value | 16 | 122 | 16 | 267 | - | - |
| Last Close Price | 2.00 | 7.35 | 4.85 | 16.17 | - | - |
| PS Ratio | - | - | 404.05 | 204.62 | - | - |
| PB Ratio | 1.08 | 2.38 | 1.17 | 2.73 | - | - |
| P/TBV Ratio | 1.46 | 2.58 | 1.25 | 2.86 | - | - |
| EV/Sales Ratio | - | - | 49.59 | 128.17 | - | - |
| Debt / Equity Ratio | 0.07 | 0.05 | 0.04 | 0.03 | 0.02 | 0.35 |
| Asset Turnover | - | - | 0.00 | 0.02 | 0.09 | - |
| Quick Ratio | 7.32 | 10.92 | 13.10 | 26.53 | 16.66 | 27.69 |
| Current Ratio | 7.99 | 11.35 | 13.50 | 27.04 | 16.73 | 27.83 |
| Return on Equity (ROE) | -71.81% | -53.36% | -38.00% | -35.01% | -74.56% | - |
| Return on Assets (ROA) | -42.35% | -32.46% | -22.38% | -20.65% | -40.66% | - |
| Return on Capital (ROIC) | -45.31% | -34.81% | -23.43% | -21.44% | -42.85% | - |
| Earnings Yield | -93.51% | -24.86% | -39.44% | -7.88% | - | - |
| FCF Yield | -84.56% | -22.92% | -35.02% | -7.26% | - | - |
| Buyback Yield / Dilution | -6.64% | -7.69% | -93.84% | -175.00% | 0.00% | - |
| Total Shareholder Return | -6.64% | -7.69% | -93.84% | -175.00% | 0.00% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.